Showing results (321-330 of 529) with videos related to
Sort By:
Pageof 53
The Journal of Clinical Endocrinology and Metabolism|April 26, 2006
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two yearsSydney Bonnick, Kenneth G Saag, Douglas P Kiel, et al.Arthritis and Rheumatism|March 6, 2013
Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritisTimothy Beukelman, Fenglong Xie, John W Baddley, et al.Journal of the National Medical Association|September 22, 2005
Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative dataTed R Mikuls, Kenneth G Saag, Jeffrey Curtis, et al.JAMA Network Open|August 15, 2022
Racial and Sex Disparities in Gout Prevalence Among US AdultsNatalie McCormick, Na Lu, Chio Yokose, et al.Health Promotion Practice|September 12, 2018
Physical Activity Maintenance Following Home-Based, Individually Tailored Print Interventions for African American WomenDori Pekmezi, Cole Ainsworth, Renee Desmond, et al.American Journal of Public Health|December 2, 2006
The impact of cost on the availability of fruits and vegetables in the homes of schoolchildren in Birmingham, AlabamaJamy D Ard, Stephanie Fitzpatrick, Renee A Desmond, et al.Journal of Cancer Survivorship : Research and Practice|January 11, 2017
A dance intervention for cancer survivors and their partners (RHYTHM)Maria Pisu, Wendy Demark-Wahnefried, Kelly M Kenzik, et al.Cancer Medicine|April 17, 2024
Understanding the financial cost of cancer clinical trial participationCourtney P Williams, Luqin Deng, Nicole E Caston, et al.Nature Clinical Practice. Rheumatology|April 10, 2008
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspectivePiet P Geusens, Christian H Roux, David M Reid, et al.Arthritis Care & Research|July 27, 2012
Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patientsJeffrey R Curtis, Fenglong Xie, Lang Chen, et al.Pageof 53